Raymond James Trust N.A. Has $511,000 Stake in Hamilton Lane Incorporated (NASDAQ:HLNE)

Raymond James Trust N.A. reduced its stake in shares of Hamilton Lane Incorporated (NASDAQ:HLNE) by 12.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,037 shares of the company’s stock after selling 426 shares during the quarter. Raymond James Trust N.A.’s holdings in Hamilton Lane were worth $511,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of HLNE. Quarry LP increased its position in shares of Hamilton Lane by 316.2% in the 2nd quarter. Quarry LP now owns 308 shares of the company’s stock valued at $38,000 after buying an additional 234 shares in the last quarter. Signaturefd LLC increased its holdings in shares of Hamilton Lane by 13.1% in the second quarter. Signaturefd LLC now owns 629 shares of the company’s stock worth $78,000 after acquiring an additional 73 shares in the last quarter. CWM LLC raised its position in shares of Hamilton Lane by 24.7% during the third quarter. CWM LLC now owns 505 shares of the company’s stock worth $85,000 after purchasing an additional 100 shares during the period. Fifth Third Bancorp lifted its holdings in shares of Hamilton Lane by 106.5% during the 2nd quarter. Fifth Third Bancorp now owns 694 shares of the company’s stock valued at $86,000 after purchasing an additional 358 shares in the last quarter. Finally, GAMMA Investing LLC grew its position in shares of Hamilton Lane by 32.4% in the 3rd quarter. GAMMA Investing LLC now owns 637 shares of the company’s stock valued at $107,000 after purchasing an additional 156 shares during the period. 97.40% of the stock is owned by institutional investors.

Hamilton Lane Price Performance

NASDAQ:HLNE opened at $199.36 on Wednesday. The stock’s 50-day simple moving average is $179.35 and its 200 day simple moving average is $149.26. Hamilton Lane Incorporated has a 52-week low of $93.98 and a 52-week high of $203.72. The company has a debt-to-equity ratio of 0.24, a quick ratio of 3.37 and a current ratio of 3.37. The company has a market cap of $11.05 billion, a P/E ratio of 43.20 and a beta of 1.18.

Hamilton Lane (NASDAQ:HLNE) last released its quarterly earnings data on Wednesday, November 6th. The company reported $1.07 EPS for the quarter, beating the consensus estimate of $1.06 by $0.01. Hamilton Lane had a return on equity of 35.59% and a net margin of 28.03%. The company had revenue of $150.00 million during the quarter, compared to the consensus estimate of $151.55 million. During the same quarter in the prior year, the firm posted $0.89 EPS. The firm’s revenue for the quarter was up 18.2% compared to the same quarter last year. As a group, sell-side analysts forecast that Hamilton Lane Incorporated will post 4.87 EPS for the current fiscal year.

Hamilton Lane Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, January 7th. Stockholders of record on Monday, December 16th will be issued a $0.49 dividend. The ex-dividend date is Monday, December 16th. This represents a $1.96 dividend on an annualized basis and a dividend yield of 0.98%. Hamilton Lane’s payout ratio is 42.52%.

Analyst Upgrades and Downgrades

Several analysts have commented on HLNE shares. Keefe, Bruyette & Woods lifted their price target on shares of Hamilton Lane from $181.00 to $215.00 and gave the company a “market perform” rating in a research note on Thursday, November 7th. JPMorgan Chase & Co. boosted their price objective on shares of Hamilton Lane from $134.00 to $175.00 and gave the company a “neutral” rating in a research report on Thursday, November 7th. The Goldman Sachs Group upped their target price on shares of Hamilton Lane from $139.00 to $147.00 and gave the stock a “neutral” rating in a research note on Thursday, October 3rd. Wells Fargo & Company lifted their price target on Hamilton Lane from $156.00 to $170.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 9th. Finally, Morgan Stanley upped their price objective on Hamilton Lane from $182.00 to $190.00 and gave the stock an “equal weight” rating in a research report on Monday, November 11th. Seven investment analysts have rated the stock with a hold rating, According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $180.33.

Hamilton Lane Company Profile

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.